CXCL12 and systemic lupus erythematosus: In this report, we examined the in vivo effect of LIT-927 in diseased MRL/lpr lupus-prone mice and found that the CXCL12 neutraligand LIT-927 significantly reduces peripheral hypercellularity that characterizes this mouse model.